1st Quarter - Amendment

INDEPENDENCE BLUE CROSS for INDEPENDENCE BLUE CROSS

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 16, 2010 — Replaced
1st Quarter - Amendment Apr 16, 2010 — Replaced
1st Quarter - Amendment (this page) May 22, 2012 $250,000 Replaced
1st Quarter - Amendment May 22, 2012 $250,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

- Issues pertaining to IRC Section 833(b) tax provisions; - Sections of Health Care Reform legislation pertaining to proposed annual insurer assessments, proposed excise tax on high-value health insurane plans, and proposed limitation of tax deduction for health insurer's executive compensation.

LobbyistCovered position, as disclosed
LORINA MARSHALL-BLAKE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Medicare Advantage Funding and Comparative Effectiveness Funding in Health Care Reform Legislation.

LobbyistCovered position, as disclosed
LORINA MARSHALL-BLAKE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

- HR 3590, "Patient Protection and Affordable Care Act", provisions regarding health care reform. - HR 4872, "The Health Care and Education Affordability Reconciliation Act of 2010", regarding health care reform; reasonable effective dates for compliance with insurance reforms; affordable premiums; federal health insurance rate authority; national insurance exchange; grandfathering. Health Care Reform; Pathway to Covering America; Employer Based Health Care System; Uninsured/Expanding Coverage; Health Care Reform Modeling; Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Health Care; Guaranteed Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate; Medical Loss Ratios; MEWAs; Government-run health insurance Plan; Government Plan Trigger; negotiated rates; state opt-out; Co-Ops; Medicare Payment Rates; Provider Underpayments; Level Playing Field; Affordable Private Health Care; proposed insurer fees; excise taxes on high value Plans; premium caps; 5 to 1 Age Rating Bands; Realistic Minimum Benefit Values; Effective Individual Mandate; Sherlock Report; Health Care Delivery System Reforms; malpractice reform; Oliver Wyman actuarial analysis "Impact of the Patient Protection and Affordable Care Act on the Costs in the Individual and Small-Employer Health Insurance Markets"; CBO premium impact analysis; New federal regulatory functions; existing state regulatory functions; Federal Exchanges; Federal Connectors; Virtual Connectors; State Insurance Marts (SIMs); Pooling; Health Care Quality; Patient-centered Primary Care/Medical Home; Health Disparities; Wellness; Chronic Care Management; Comparative Effectiveness Research; Improved Delivery of Health Care; evidence based care; Health Care Delivery System Reforms; Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative Simplification; Antitrust and Health Insurance Reform; McCarran-Ferguson antitrust exemption repeal legislation: HR 4626, "Health Insurance Industry Fair Competition Act"; Scope of FEHBP preemption.

LobbyistCovered position, as disclosed
LORINA MARSHALL-BLAKE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4872 (111th), H.R. 3590 (111th), H.R. 4626 (111th)

Medicare/Medicaid MMM

Issues pertaining to Medicare Advantage.

LobbyistCovered position, as disclosed
LORINA MARSHALL-BLAKE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

HR 4489, "To amend Chapter 89 of Title 5, United States Code, to ensure program integirty, transparency, and cost savings in the pricing and contracting of prescription drug benefits under the Federal Employees Health Benefit Program", regarding all provisions.

LobbyistCovered position, as disclosed
LORINA MARSHALL-BLAKE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4489 (111th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.